Insiders trading at Medpace Inc
Over the last 8 years, insiders at Medpace Inc have traded over $3,140,136,825 worth of Medpace Inc stock and bought 2,899,276 units worth $330,034,155 . The most active insiders traders include Limited Partnership Medpace..., August J. Troendle и Investors, Llc Medpace. On average, Medpace Inc executives and independent directors trade stock every 9 days with the average trade being worth of $40,224,347. The most recent stock trade was executed by Robert O. Kraft on 22 August 2024, trading 8,127 units of MEDP stock currently worth $346,373.
What does Medpace Inc do?
a therapeutically focused leader in research-based drug development, medpace builds strong strategic partnerships with select sponsors to advance the most efficient and cost-effective path to drug approval. as a full service, global clinical research organization (cro), medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial. from custom solutions addressing the needs of small and midsize biotechnology companies to full-service offerings for global pharmaceutical companies, medpace has the breadth, depth, and flexibility to deliver a superior result, specific to your needs, on six continents.
What does Medpace Inc's logo look like?
Medpace Inc executives and stock owners
Medpace Inc executives and other stock owners filed with the SEC include:
-
August Troendle,
Chairman of the Board, President, Chief Executive Officer -
Susan Burwig,
Executive Vice President - Operations -
Jesse Geiger,
Chief Financial Officer, Chief Operating Officer - Laboratory Operations -
Stephen Ewald,
General Counsel, Corporate Secretary -
Dr. August James Troendle M.D.,
Chairman & CEO -
Susan E. Burwig,
Exec. VP of Operations -
Jesse J. Geiger BBA, CPA,
Pres -
Stephen P. Ewald,
Chief Compliance Officer, Gen. Counsel & Corp. Sec. -
Brian Carley,
Independent Director -
Robert Kraft,
Independent Director -
Fred Davenport,
Lead Independent Director -
Cornelius McCarthy,
Independent Director -
Ashley Keating,
Independent Director -
Thomas King,
Independent Director -
Brandon Ebken,
Chief Information Officer -
John T. Wynne,
Sr. VP of Commercial Operations & Clinical Pharmacology Unit -
Daniel O'Leary,
Sr. VP of Medical Department -
Weimin Gai MS,
Sr. VP of Biometrics -
Todd Meyers,
VP of Bus. Devel. & Marketing -
Lauren Morris,
Associate Director of Investors Relations -
Kevin M. Brady,
CFO & Treasurer -
Penelope J Bucknell,
VP, Human Resources -
Bruce Brown,
Director -
Cinven Fund (No. 1) Limited...,
-
Limited Partnership Medpace...,
-
Dani S. Zander,
Director -
Investors, Llc Medpace,
10% owner -
Tom C King,
Director -
Kevin M. Brady,
CFO & Treasurer